fbpx
WhatsApp: +1 (780) 996-0049
+1 (780) 996-0049

Provisional Patent Acquisition

"Natural Medicine Extractors"

Provisional Patent Acquisition

Calgary, Alberta – April 13, 2021.

For Immediate Release – Medxtractor Corp. (“MXT”) announces acquisition of a provisional US patent related to SHAMAN’s foundational processes.

Medxtractor Corp. (the “MXT”) reports that it has acquired all rights to United States Provisional Patent application number 63132186, “Novel Method of Generating Credible Solutions from Non-validated Datasets” (the “Application”). The Application was created by MXT President Jim Durward and was accepted for filing by the United States Patent Office on December 30, 2020. A full patent application is being prepared and will be filed in due course. Conditions of the transfer include MXT’s payment of all patent-associated and commercialization expenses and MXT’s continued pursuance of the Application. MXT’s SHAMAN project is structured on the Application processes.

Jim Durward, President, states: “There has been significant activity in intellectual property developments related to digital diagnosis in the health sector and as recently as March 31, 2021 Mind Cure Health (“MCUR” – CSE) filed a provisional patent related to its iSTRYM digital therapeutics application. It became apparent to me that foundational infrastructure was not being adequately addressed and will be a prime application in the future. Based on my extensive experience in data conditioning, analysis and pattern recognition, a provisional patent application was filed with the US Patent Office on December 30, 2020. Today, for the benefit of all MXT shareholders, I have agreed to transfer all rights to this Application to MXT for the sum of $1.00″.

 

ABOUT MEDXTRACTOR CORP:

The Corporation is a Calgary-based company that generates technologically-based solutions. With installations all over the world, its patented craft-scale bio-extractors are used to extract compounds from a variety of botanical materials. The SHAMAN division is focusing on applying machine learning to predict potential benefits associated with the use of psychedelic drugs within the mental health misdiagnosis problem.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

MEDXTRACTOR CORP.

James M. Durward, President and CEO                                                                                           

Telephone: (403) 689-3901                                                                                                                 

Email:   [email protected]

Website: www.medxtractor.com or www.shaman-ai.com

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States.  The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Leave a Reply

Your email address will not be published.

Feature of the month

HURRY! 3oz CO2 extractor $500 OFF until JULY 31, 2022!

Use code 3OZSPECIAL